Suleman Chitera 
By Suleman Chitera, MFN Reporter
October 24, 2026
Philanthropist and business tycoon Thom Mpinganjira has invested approximately K16 billion in the establishment of a state-of-the-art diagnostic centre at the International Blantyre Cancer Centre (IBCC), in a major boost to Malawi’s healthcare sector.
The facility, launched on Friday night in Blantyre, houses advanced diagnostic machines, some of which are reported to be the first of their kind in Africa.
The centre is expected to improve access to specialised medical investigations, reduce the need for patients to travel abroad for diagnosis and help save lives through improved disease detection.
Speaking during the launch, Mpinganjira said he hoped the investment would help save lives that might otherwise be lost because of the country’s limited access to advanced diagnostic services.
His investment comes at a time when some Malawians requiring specialised medical investigations have had to seek services outside the country, increasing costs for patients and putting additional pressure on Malawi’s foreign exchange reserves.
The new facility is expected to strengthen the country’s capacity to diagnose complex illnesses locally, potentially enabling patients to access appropriate medical attention without the additional burden of travelling abroad.
Ministry of Health Principal Secretary Bestone Chisamile said Malawi spends more than K3 billion on diagnostic referrals outside the country.
Chisamile expressed optimism that the establishment of the IBCC Diagnostic Centre would help reduce this expenditure by allowing more patients to undergo specialised investigations within Malawi.
Reducing overseas referrals could help the country conserve foreign exchange while easing some of the financial and logistical challenges faced by patients and their families.
The facility also presents an opportunity for Malawi to generate foreign currency by attracting patients from other countries seeking specialised diagnostic services.
If successfully developed into a regional referral centre, IBCC could contribute to the growth of Malawi’s private healthcare sector and strengthen the country’s position in specialised medical services.
Beyond its potential economic benefits, the centre’s significance lies in its capacity to bring advanced diagnostic technology closer to patients who need it.
Early and accurate diagnosis is essential in the management of serious illnesses, including cancer, because it helps medical professionals determine appropriate treatment options.
The availability of sophisticated diagnostic equipment in Malawi could therefore help reduce delays associated with overseas referrals, although actual benefits will depend on the services offered, their affordability and access to qualified medical personnel.
Mpinganjira’s K16 billion investment highlights the potential role of private-sector investment and philanthropy in addressing gaps in Malawi’s healthcare system.
As the facility begins its operations, its long-term impact will depend on its ability to provide reliable diagnostic services, serve patients effectively and contribute to better health outcomes.
For a country spending billions of kwacha on medical referrals abroad, the establishment of the IBCC Diagnostic Centre offers fresh hope for improved access to specialised diagnosis, reduced pressure on foreign exchange and potentially better outcomes for patients.
The ultimate measure of the investment, however, will be the lives it helps save and the number of patients who can access quality diagnostic services without leaving Malawi.
